Skip to content
← All treatment topics

TREATMENT READING

Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors

Choose a source section by treatment, subtype or setting. Patient and professional reading are labelled separately.

Selected text from the National Cancer Institute, with original links and dates. This Triangle reading page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.

8 studies cited in this topic · see design and results →

Explore 4 related disease and treatment settings → · Source-derived catalogue; clinical review pending.

23 sections · Source headings, not a ranked treatment list

For patients · General Information About Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors

Certain factors affect prognosis (chance of recovery) and treatment options.

For patients · Staging Childhood Medulloblastoma, Other Central Nervous System Embryonal Tumors, and Pineoblastoma

Medulloblastoma, other CNS embryonal tumors, and pineoblastoma in children are treated based on the tumor type and the child's age.

For patients · Staging Childhood Medulloblastoma, Other Central Nervous System Embryonal Tumors, and Pineoblastoma

Treatment of medulloblastoma in children older than 3 years also depends on whether the tumor is average risk or high risk.

For patients · Staging Childhood Medulloblastoma, Other Central Nervous System Embryonal Tumors, and Pineoblastoma / Treatment of medulloblastoma in children older than 3 years also depends on whether the tumor is average risk or high risk.

Average risk

For patients · Staging Childhood Medulloblastoma, Other Central Nervous System Embryonal Tumors, and Pineoblastoma / Treatment of medulloblastoma in children older than 3 years also depends on whether the tumor is average risk or high risk.

High risk

For patients · Staging Childhood Medulloblastoma, Other Central Nervous System Embryonal Tumors, and Pineoblastoma

The results of the tests and procedures done to diagnose medulloblastoma, other CNS embryonal tumors, and pineoblastoma in children are used to plan cancer treatment.

For patients · Staging Childhood Medulloblastoma, Other Central Nervous System Embryonal Tumors, and Pineoblastoma

Sometimes childhood medulloblastoma and other central nervous system embryonal tumors come back after treatment.

For patients

Treatment Option Overview

For patients · Treatment Option Overview

Key Points

For patients · Treatment Option Overview

There are different types of treatment for children who have medulloblastoma and other central nervous system (CNS) embryonal tumors.

For patients · Treatment Option Overview

Children who have medulloblastoma, other CNS embryonal tumors, and pineoblastoma should have their treatment planned by a team of health care providers who are experts in treating brain tumors in children.

For patients · Treatment Option Overview

The following types of treatment may be used:

For patients · Treatment Option Overview / The following types of treatment may be used:

Surgery

For patients · Treatment Option Overview / The following types of treatment may be used:

Radiation therapy

For patients · Treatment Option Overview / The following types of treatment may be used:

Chemotherapy

For patients · Treatment Option Overview / The following types of treatment may be used:

High-dose chemotherapy with autologous stem cell rescue

For patients · Treatment Option Overview / The following types of treatment may be used:

Targeted therapy

For patients · Treatment Option Overview

New types of treatment are being tested in clinical trials.

For patients

Treatment of Childhood Medulloblastoma

For patients

Treatment of Other CNS Embryonal (nonmedulloblastoma) Tumors in Children

For patients

Treatment of Childhood Pineoblastoma

For patients

Treatment of Recurrent Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors

For patients · Side Effects

The tumor and the treatment may cause symptoms that continue after treatment ends.

Preserved source evidence · Independent clinical review pending · Not medical advice